Macaluso steps up as Ampio CEO takes compassionate leave
This article was originally published in Scrip
Executive Summary
Don Wingerter, CEO of Ampio Pharmaceuticals, a company that discovers new uses for previously approved drugs, has been granted compassionate leave of indefinite length from all his duties to attend to the serious health problems afflicting his parents. Filling the breach is Michael Macaluso, current chair of the Ampio board of directors and lead investor in DMI BioSciences, predecessor company to Ampio.